Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRADIMED CORPIRMD · Entity 4896 | VP of Reg. and Qual. Assurance | December 31, 2019 | January 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRADIMED CORP
Report date December 31, 2019 · Filed January 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,474 |
Ending reported balance
After 2019-12-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-12-31 · Exercise / conversion · Acquired 388 · Balance 53,569 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2019-12-31 · Tax withholding · Disposed 95 · Balance 53,474 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-12-31 · Exercise / conversion · Disposed 388 · Balance 0 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2019 Filed Jan 3, 2020 19:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000016 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 95 | $23.38 | $2,221.10 |
DisclosureSEC source: 0000898432-20-000016 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,474 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000016 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 104 | $25.67 | $2,669.68 |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,181 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · derivative · entry 4 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,748 Underlying: Common Stock · 1,748 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 96 | $22.88 | $2,196.48 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,860 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001353 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $22.28 | $4,010.40 |
DisclosureSEC source: 0000898432-19-001353 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,563 Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:27 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001353 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 95 | $24.46 | $2,323.70 |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,005 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 104 | $27.02 | $2,810.08 |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,712 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:41 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001461 · form4.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 178 | $26.78 | $4,766.84 |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,391 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 16:56 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 47,948 | $29.12 | $1,396,274.53 |
DisclosureSEC source: 0000898432-18-001012 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,831 F2 · price: This transaction was executed in multiple trades at prices ranging from $28.15 to $30.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 16:56 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 7,052 | $30.51 | $215,129.02 |
DisclosureSEC source: 0000898432-18-001012 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,779 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.25 to $30.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 17:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 35,000 | $18.50 | $647,524.50 |
DisclosureSEC source: 0000898432-18-000707 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,831 F1 · price: This transaction was executed in multiple trades at prices ranging from $18.50 to $18.575. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 103 | $15.15 | $1,560.45 |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,831 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000005 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 139 | $13.10 | $1,820.90 |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,546 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 18:01 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001304 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:49 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045235 · doc1.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 Underlying: Common Stock · 387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 127 | $12.30 | $1,562.10 |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,260 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001005 · doc1.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 19:53 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090125 · doc1.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg & Qual Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.